Latin America At Home Testing Kits Market
Tamanho do mercado em biliões de dólares
CAGR : %
Período de previsão |
2024 –2031 |
Tamanho do mercado (ano base ) | USD 525.88 Million |
Tamanho do mercado ( Ano de previsão) | USD 755.84 Million |
CAGR |
|
Principais participantes do mercado |
Latin America At-Home Testing Kits Market Segmentation, Test Type (Pregnancy Test, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kits, and Other Test Types), Type (Cassettes, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Other Sample Types), Usage (Disposable and Reusable), Distribution Channel (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies) – Industry Trends and Forecast to 2031
Latin America At-Home Testing Kits Market Analysis
The at-home testing kits market in Latin America has shown significant growth, driven by increasing healthcare awareness and a rising demand for convenient diagnostic solutions. The prevalence of chronic diseases, including diabetes and hypertension, is notably high in the region, affecting a substantial portion of the population and prompting a shift towards self-monitoring solutions. Additionally, it is estimated that the market penetration of at-home testing kits could reach around 15% by 2025, reflecting increased consumer acceptance and the growing availability of a variety of testing options.
Latin America At-Home Testing Kits Market Size
Latin America at-home testing kits market size was valued at USD 525.88 million in 2023 and is projected to reach USD 755.84 million by 2031, with a CAGR of 4.7% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Latin America At-Home Testing Kits Market Trends
“Increasing Consumer Demand for Convenient and Accessible Healthcare Solutions”
A significant trend in the Latin America at-home testing kits market is the increasing consumer demand for convenient and accessible healthcare solutions, especially in the wake of the COVID-19 pandemic. As individuals become more health-conscious, there is a rising preference for at-home testing kits that allow for self-diagnosis of various conditions, including infectious diseases, chronic illnesses, and even genetic testing. This shift is driven by factors such as the desire for privacy, ease of use, and the need to reduce hospital visits. Furthermore, the expansion of e-commerce platforms and mobile health applications has facilitated the distribution and accessibility of these kits, making it easier for consumers to order and utilize them from the comfort of their homes. As a result, this trend has prompted manufacturers and healthcare companies to innovate and diversify their product offerings, catering to an increasingly proactive consumer base seeking to manage their health more independently.
Report Scope and Latin America At-Home Testing Kits Market Segmentation
Attributes |
Latin America At-Home Testing Kits Market Insights |
Segments Covered |
|
Countries Covered |
Mexico, Brazil, Argentina, and rest of Latin America |
Key Market Players |
Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthineers AG (Europe), B. Braun SE (Germany), ACON Laboratories, Inc (U.S.), ARKRAY, Inc. (Japan), OraSure Technologies, Inc (U.S.), SA Scientific Ltd. (U.S.), QuidelOrtho Corporation (U.S.), PRIMA Lab SA (Switzerland), and Bionime Corporation (Taiwan) among others |
Market Opportunities |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Latin America At-Home Testing Kits Market Definition
At-home testing kits means testing instruments which help person to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, infectious diseases such as malaria, and others. For performing these rapid at-home tests blood, urine and oral fluid can be taken as a sample.
Latin America At-Home Testing Kits Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The need for early detection also drives this demand. Chronic diseases often progress gradually, and early identification of abnormal health indicators can make a significant difference in preventing the worsening of conditions. At-home testing kits offer patients the ability to perform regular self-checks, helping them catch warning signs early and seek timely medical intervention. Additionally, the convenience of home-based testing reduces the time, effort, and costs associated with frequent doctor visits, which is an appealing factor for patients managing long-term conditions.
Moreover, the increasing burden on healthcare systems in Latin America is contributing to the popularity of at-home testing kits. Many public healthcare systems are struggling with overcrowded hospitals and limited resources, and at-home testing reduces the pressure on these systems by minimizing the number of routine visits for diagnostic purposes. This is particularly important in Latin America, where healthcare access can vary widely depending on geography and socioeconomic status.
- Growing Adoption of Self-Testing Kits
Earlier, people frequently visited hospitals even for basic health concerns. However, with increasing awareness about at-home testing products, this behavior has shifted significantly. Today, many consumers prefer to use self-testing kits at home for basic tests before consulting a doctor. This growing trend offers convenience, as individuals can quickly access their test results with ease. In Latin America, the rising adoption of self-testing kits is a key driver of the At-Home Testing Kits Market, especially in regions with limited healthcare infrastructure. These kits provide an affordable, reliable, and convenient solution for patients to monitor their health, reducing the need for frequent hospital visits. They are particularly beneficial in rural and underserved areas, enabling early detection and management of conditions such as diabetes, COVID-19, and sexually transmitted infections. By decreasing hospital overcrowding and lowering consultation and diagnostic fees, self-testing kits not only improve healthcare access but also help curb hospital expenses, making them a practical solution for both patients and healthcare systems.
Opportunities
- Advent Of Advanced Technologies such as AI and Machine Learning
The latest technologies are playing crucial role to make the medical products very advance and reliable to trust. Artificial Intelligence (AI) and Machine Learning (ML) in various medical devices is an important part of the healthcare industry with the potential to improve patient care, as well as administrative processes by automating tasks and achieving faster results.
It is for sure that AI powered diagnostic tools and instruments by nature will continue to evolve. In the healthcare industry, AI has only made small steps towards a vast and multidimensional opportunity.
- Rise in the Adoption of Self-Testing Kits Via Online Against Conventional Approach
Today, more and more people are adopting the online shopping whether it is for apparels or for groceries or healthcare products. People are now adopting online platforms to buy genuine medical instruments and medicines. During the ongoing pandemic, many health conscious consumers went online to buy a wide range of health and wellness products. At-home testing kits for many medical conditions are now made available online via e-commerce website or from the company’s website as well.
Some companies including Everlywell and LetsGetChecked, also offers at-home collection of specimen and then take it to the certified laboratories for testing and delivering the results in 2-3 days with certified professional. These companies are gaining customer confidence through their certified lab processes test results and providing complete privacy. Many companies are themselves delivering their self-testing kits to the person.
Restraints/Challenges
- Inaccuracy of Results by Self-Testing Kits
At-home testing kits allows end-user to collect their specimen at home and then either perform the tests at home or can send that specimen to lab for testing. At-home testing kits are undoubtedly eased the process of confirming about the concern of the person either it is home pregnancy test or HIV test or any other infectious diseases tests. These home tests are not only easy to use but they are affordable too. However, there is always a doubt in the accuracy of the results.
However, a false positive result of a test may cause anxiety and stress to the person, even if they do not have. It is very upsetting and disturbing to the person to receive a false positive or negative result. There are various accuracy related issues due to which the distribution of at-home test kits has been suspended to verify its reliability.
- Limited Awareness and Education
Limited awareness and education present significant challenges for the at-home testing kits market in Latin America. Many consumers are unaware of the benefits and availability of these testing kits, which can impede their willingness to adopt them. This issue is particularly pronounced in rural areas, where access to information and health literacy levels may be lower. Without a proper understanding of these tools, individuals may not recognize their value, leading to skepticism regarding their accuracy and effectiveness. Consequently, this gap in awareness can result in missed opportunities for early diagnosis and prevention of health issues, ultimately impacting public health outcomes in these communities.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Latin America At-Home Testing Kits Market Scope
The market is segmented on the basis of test type, type, age, sample type, usage, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Pregnancy Test
- Hiv Test Kit
- Diabetes
- Infectious Diseases
- Glucose Tests
- Ovulation Predictor Test Kit
- Drug Abuse Test Kit
- Other Test Types.
Type
- Cassette
- Strip
- Midstream
- Test Panel
- Dip Card
- Other Form Types
Age
- Pediatric
- Adult
- Geriatric
Sample Type
- Urine
- Blood
- Saliva
- Other Sample Types
Usage
- Disposable
- Reusable
Distribution Channel
- Retail Pharmacies
- Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
Latin America At-Home Testing Kits Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, test type, type, age, sample type, usage, distribution channel as referenced above.
The countries covered in the market are Mexico, Brazil, Argentina and rest of Latin America.
Mexico is expected to dominate the market due to its well-established healthcare infrastructure and high adoption rate of advanced technologies, including cloud-based solutions and automation. Supportive government initiatives and significant investments in healthcare IT drive innovation and enhance the efficiency of laboratory operations in the region.
Brazil is expected to be the fastest growing due to rapid advancements in healthcare infrastructure and an increasing focus on adopting digital health solutions. Also, the rising prevalence of chronic diseases and the need for efficient laboratory management systems further fuel the demand for LIS in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Latin America At-Home Testing Kits Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Latin America At-Home Testing Kits Market Leaders Operating in the Market Are:
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S.)
- Siemens Healthineers AG (Germany)
- B. Braun SE (Europe)
- ACON Laboratories, Inc (U.S.)
- ARKRAY, Inc. (Japan)
- OraSure Technologies, Inc (U.S.)
- SA Scientific Ltd. (U.S.)
- QuidelOrtho Corporation (U.S.)
- PRIMA Lab SA (Switzerland)
- Bionime Corporation (Taiwan)
Latest Developments in Latin America At-Home Testing Kits Market
- In September 2024, Agilent Technologies Inc. announced the completion of its acquisition of BIOVECTRA, enhancing its contract development and manufacturing capabilities. This move expanded Agilent's CDMO services and supported gene editing, reflecting its commitment to advancing therapeutics programs with best-in-class manufacturing
- In July 2021, STARLIMS Corporation had signed a definitive agreement with Francisco Partners for the STARLIMS informatics product suite and related business assets from Abbott. This partnership will further help the company to get well positioned for continued growth in the competitive market
- In April 2023, Microsoft and Epic has expanded their partnership to integrate generative AI into healthcare, leveraging Azure OpenAI Service with Epic's EHR software. This collaboration aims to boost productivity, enhance patient care, and improve the financial integrity of health systems worldwide
- In October 2024, Xybion has launched LIMS 10.0, a modern, AI-enabled solution enhancing lab efficiency across industries. Featuring an intuitive interface, integrated QMS, and robust functionalities like inventory management and audit trails, it transforms laboratory operations and accelerates compliance and throughput globally
- In September 2024, LabVantage Solutions partnered with Henkel to create an integrated R&D platform, connecting LabVantage LIMS and SAP PLM. This collaboration aimed to streamline processes, enhance data sharing, and drive digital transformation in Henkel’s consumer brands division
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF LATIN AMERICA AT-HOME TESTING KITS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 LATIN AMERICA OUTSOURCING TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 LATIN AMERICA AT-HOME TESTING KITS MARKET: REGULATIONS
5.1 REGULATIONS IN LATIN AMERICA
5.1.1 RESEARCH AND DEVELOPMENT (R&D)
5.1.1.1 CLINICAL TRIALS & PRODUCT DEVELOPMENT:
5.1.2 REGULATORY APPROVAL AND MARKET AUTHORIZATION
5.1.2.1 HEALTH AUTHORITIES AND REGULATORY BODIES:
5.1.2.2 REGISTRATION PROCESS:
5.1.3 RAW MATERIALS AND MANUFACTURING STANDARDS
5.1.3.1 GOOD MANUFACTURING PRACTICES (GMP):
5.1.3.2 SUPPLY CHAIN MANAGEMENT:
5.1.4 PRODUCT LABELING AND PACKAGING
5.1.4.1 REGULATORY REQUIREMENTS FOR LABELING:
5.1.4.2 MULTI-LANGUAGE LABELING:
5.1.5 SUPPLY & DISTRIBUTION
5.1.5.1 DISTRIBUTION LICENSING:
5.1.5.2 CUSTOMS AND IMPORTATION:
5.1.5.3 DISTRIBUTOR RESPONSIBILITIES:
5.1.6 POST-MARKET SURVEILLANCE & MONITORING
5.1.6.1 ADVERSE EVENT REPORTING:
5.1.6.2 QUALITY CONTROL AND PERIODIC AUDITS:
5.1.6.3 POST-MARKET CLINICAL STUDIES:
5.1.6.4 CERTIFICATION RENEWALS:
5.1.7 PRICING AND REIMBURSEMENT
5.1.7.1 PRICING REGULATION:
5.1.7.2 REIMBURSEMENT POLICIES:
5.1.8 SPECIFIC CONSIDERATIONS FOR PUBLIC HEALTH EMERGENCIES
5.1.8.1 EMERGENCY USE AUTHORIZATION (EUA):
5.1.8.2 TEMPORARY APPROVALS AND EXPEDITED REVIEWS:
5.1.9 HARMONIZATION WITH INTERNATIONAL STANDARDS
5.1.9.1 INTERNATIONAL GUIDELINES:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING ADOPTION OF SELF-TESTING KITS
6.1.3 EASY AVAILABILITY OF SELF-TESTING KIT
6.1.4 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS
6.2 RESTRAINTS
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS
6.2.2 LIMITED AWARENESS AND EDUCATION
6.3 OPPORTUNITIES
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES SUCH AS AI AND MACHINE LEARNING
6.3.2 RISE IN THE ADOPTION OF SELF-TESTING KITS VIA ONLINE AGAINST CONVENTIONAL APPROACH
6.3.3 INCREASE IN STRATEGIC DECISIONS AMONGST COMPANIES AND ORGANIZATIONS
6.4 CHALLENGE
6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY
7 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TYPE
7.1 OVERVIEW
7.2 STRIP
7.3 CASSETTES
7.4 MIDSTREAM
7.5 DIP CARD
7.6 TEST PANEL
7.7 OTHERS
8 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY AGE
8.1 OVERVIEW
8.2 ADULT
8.3 GERIATRIC
8.4 PEDIATRIC
9 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
9.1 OVERVIEW
9.2 GLUCOSE TESTS
9.3 INFECTIOUS DISEASES
9.3.1 HIV TEST KIT
9.3.1.1 ADULT
9.3.1.2 GERIATRIC
9.3.1.3 PEDIATRIC
9.3.1.4 ONLINE
9.3.1.5 RETAIL
9.3.1.6 OTHERS
9.3.2 COVID/ RESPIRATORY TEST KIT
9.3.2.1 ADULT
9.3.2.2 GERIATRIC
9.3.2.3 PEDIATRIC
9.3.2.4 ONLINE
9.3.2.5 RETAIL
9.3.2.6 OTHERS
9.3.3 HEPATITIS C TEST KIT
9.3.3.1 ADULT
9.3.3.2 GERIATRIC
9.3.3.3 PEDIATRIC
9.3.3.4 ONLINE
9.3.3.5 RETAIL
9.3.3.6 OTHERS
9.3.4 OTHERS
9.4 PREGNANCY TEST
9.5 DRUG ABUSE TEST KITS
9.6 OVULATION PREDICTOR TEST KIT
9.7 OTHER TEST TYPES
10 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 SALIVA
10.4 URINE
10.5 OTHER SAMPLE TYPES
11 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY USAGE
11.1 OVERVIEW
11.2 DISPOSABLE
11.3 REUSABLE
12 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL PHARMACIES
12.3 DRUG STORE
12.4 SUPERMARKET/HYPERMARKET
12.5 ONLINE PHARMACIES
13 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY COUNTRY
13.1 LATIN AMERICA
13.1.1 MEXICO
13.1.2 BRAZIL
13.1.3 ARGENTINA
13.1.4 REST OF LATIN AMERICA
14 LATIN AMERICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: LATIN AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 F. HOFFMANN-LA ROCHE LTD.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 BD
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 SIEMENS HEALTHINEERS AG
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 QUIDELORTHO CORPORATION
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 ACON LABORATORIES, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ARKRAY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 B. BRAUN SE
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BIONIME CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 ORASURE TECHNOLOGIES, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 PRIMA LAB SA
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 SA SCIENTIFIC LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 3 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 LATIN AMERICA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 LATIN AMERICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 6 LATIN AMERICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 7 LATIN AMERICA COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 8 LATIN AMERICA COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 9 LATIN AMERICA HEPATITIS C TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 10 LATIN AMERICA HEPATITIS C TEST KIT TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 11 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2022-2031 (USD THOUSAND)
TABLE 13 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 14 LATIN AMERICA AT-HOME TESTING KITS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 15 MEXICO AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 MEXICO INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 17 MEXICO HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 18 MEXICO HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 MEXICO COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 20 MEXICO COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 21 MEXICO HEPATITIS C TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 22 MEXICO HEPATITIS C TEST KIT TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 23 MEXICO AT-HOME TESTING KITS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 MEXICO STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 25 MEXICO CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 26 MEXICO MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 27 MEXICO DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 28 MEXICO TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 29 MEXICO AT-HOME TESTING KITS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 30 MEXICO AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 31 MEXICO AT-HOME TESTING KITS MARKET, BY USAGE, 2022-2031 (USD THOUSAND)
TABLE 32 MEXICO AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 33 BRAZIL AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 34 BRAZIL INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 BRAZIL HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 36 BRAZIL HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 37 BRAZIL COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 38 BRAZIL COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 39 BRAZIL HEPATITIS C TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 40 BRAZIL HEPATITIS C TEST KIT TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 41 BRAZIL AT-HOME TESTING KITS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 BRAZIL STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 43 BRAZIL CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 44 BRAZIL MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 45 BRAZIL DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 46 BRAZIL TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 47 BRAZIL AT-HOME TESTING KITS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 48 BRAZIL AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 BRAZIL AT-HOME TESTING KITS MARKET, BY USAGE, 2022-2031 (USD THOUSAND)
TABLE 50 BRAZIL AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 51 ARGENTINA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 52 ARGENTINA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 53 ARGENTINA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 54 ARGENTINA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 55 ARGENTINA COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 56 ARGENTINA COVID/ RESPIRATORY TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 57 ARGENTINA HEPATITIS C TEST KIT IN AT-HOME TESTING KITS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 58 ARGENTINA HEPATITIS C TEST KIT TEST KIT IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 59 ARGENTINA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 ARGENTINA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 ARGENTINA HIV TEST KIT BY AGE GROUP IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 ARGENTINA HIV TEST KIT BY DISTRIBUTION CHANNEL IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 ARGENTINA COVID/ RESPIRATORY TEST KIT BY AGE GROUP IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 ARGENTINA COVID/ RESPIRATORY TEST KIT BY DISTRIBUTION CHANNEL IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 65 ARGENTINA HEPATITIS C TEST KIT BY AGE GROUP IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 ARGENTINA HEPATITIS C TEST KIT TEST KIT BY DISTRIBUTION CHANNEL IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 67 ARGENTINA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 ARGENTINA AT-HOME TESTING KITS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 ARGENTINA STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 70 ARGENTINA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 71 ARGENTINA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 72 ARGENTINA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 73 ARGENTINA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 ARGENTINA AT-HOME TESTING KITS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 75 ARGENTINA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 76 ARGENTINA AT-HOME TESTING KITS MARKET, BY USAGE, 2022-2031 (USD THOUSAND)
TABLE 77 ARGENTINA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 78 REST OF LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
Lista de Figura
FIGURE 1 LATIN AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 2 LATIN AMERICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION
FIGURE 3 LATIN AMERICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS
FIGURE 4 LATIN AMERICA AT-HOME TESTING KITS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 LATIN AMERICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 LATIN AMERICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 LATIN AMERICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 LATIN AMERICA AT-HOME TESTING KITS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 LATIN AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 10 SIX SEGMENTS COMPRISE THE LATIN AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
FIGURE 11 STRATEGIC DECISIONS
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE LATIN AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 GLUCOSE TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF LATIN AMERICA AT-HOME TESTING KITS MARKET IN 2024 & 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR LATIN AMERICA AT-HOME TESTING KITS MARKET
FIGURE 16 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2023
FIGURE 17 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 18 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2023
FIGURE 21 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2024-2031 (USD THOUSAND)
FIGURE 22 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2024-2031)
FIGURE 23 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE
FIGURE 24 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2023
FIGURE 25 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND)
FIGURE 26 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 27 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 28 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2023
FIGURE 29 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 30 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2024-2031)
FIGURE 31 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 32 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2023
FIGURE 33 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2024-2031 (USD THOUSAND)
FIGURE 34 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2024-2031)
FIGURE 35 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE
FIGURE 36 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 37 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 38 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 39 LATIN AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 LATIN AMERICA AT-HOME TESTING KITS MARKET: SNAPSHOT, 2023
FIGURE 41 LATIN AMERICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2023 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.